Novel Therapy for Glucose Intolerance in HIV Disease

Completed · Has a placebo group

Conditions studied: Insulin Resistance

In brief

This research is to investigate the nutritional supplement chromium picolinate. The investigators are testing to see how effective this supplement is in treating insulin resistance associated with HIV disease.

Key facts

Study ID
NCT02006914
Run by
Stony Brook University
People needed
47
Starts
2005-06-01
Expected to finish
2012-04-01
Last updated by the study team
2013-12-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.